BEAM:BMV
Beam Therapeutics Inc
453,00 MX$
0,00%
(0,00) 1D
8 ოქტ, 07:30:20 GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Mkt. cap
2,65 მლრდ.
Avg. vol.
13,00
Volume
0,00
52-wk high
663,44 MX$
52-wk low
384,79 MX$
No. of employees
540
Mkt. cap
2,65 მლრდ.
Avg. vol.
13,00
Volume
0,00
52-wk high
663,44 MX$
52-wk low
384,79 MX$
No. of employees
540
News stories
From web sources and news partners
The Motley Fool
·
7 წუთის წინ
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Yahoo Finance
·
1 საათის წინ
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
The Globe and Mail
·
1 საათის წინ
How to Beat a Choppy Market With 4 Steady Stocks
24/7 Wall St.
·
4 საათის წინ
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc